- Home
- BJDX vs BDRX Comparison
BJDX vs BDRX Comparison
Compare BJDX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJDX
- BDRX
- Stock Information
- Founded
- BJDX 2015
- BDRX 2000
- Country
- BJDX United States
- BDRX United Kingdom
- Employees
- BJDX N/A
- BDRX N/A
- Industry
- BJDX Medical Specialities
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- BJDX Health Care
- BDRX Health Care
- Exchange
- BJDX Nasdaq
- BDRX Nasdaq
- Market Cap
- BJDX 2.2M
- BDRX 2.4M
- IPO Year
- BJDX 2021
- BDRX N/A
- Fundamental
- Price
- BJDX $3.70
- BDRX $1.54
- Analyst Decision
- BJDX
- BDRX
- Analyst Count
- BJDX 0
- BDRX 0
- Target Price
- BJDX N/A
- BDRX N/A
- AVG Volume (30 Days)
- BJDX 35.9K
- BDRX 3.5M
- Earning Date
- BJDX 05-14-2025
- BDRX 04-21-2025
- Dividend Yield
- BJDX N/A
- BDRX N/A
- EPS Growth
- BJDX N/A
- BDRX N/A
- EPS
- BJDX N/A
- BDRX N/A
- Revenue
- BJDX N/A
- BDRX $104,895.00
- Revenue This Year
- BJDX N/A
- BDRX N/A
- Revenue Next Year
- BJDX N/A
- BDRX N/A
- P/E Ratio
- BJDX N/A
- BDRX N/A
- Revenue Growth
- BJDX N/A
- BDRX N/A
- 52 Week Low
- BJDX $3.03
- BDRX $1.14
- 52 Week High
- BJDX $316.80
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- BJDX 45.28
- BDRX 35.57
- Support Level
- BJDX $3.52
- BDRX $1.14
- Resistance Level
- BJDX $4.02
- BDRX $2.65
- Average True Range (ATR)
- BJDX 0.32
- BDRX 0.24
- MACD
- BJDX -0.05
- BDRX 0.01
- Stochastic Oscillator
- BJDX 14.06
- BDRX 26.49
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.